admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

atai Life Sciences to Participate in the Cowen 43rd Annual Health...

Psychedelic Health – Psychedelics Today: improving access to psychedelic therapy training

Mycoprenuer Podcast – Joe Moore & Kyle Buller: Psychedelics Today

Small Pharma to Present at Cowen’s 43rd Annual Health Care Conference

Optimi Health Enters Australian Medical MDMA And Psilocybin Market With Mind...

Algernon Pharmaceuticals Announces 4 for 1 Forward Share Split

Blossom – Making Psychedelic Education Accessible with David Drapkin from Psychedelics...

Fierce Healthcare – Psychedelics Today to offer yearlong certificate course on...

1...828384...218 Page 83 of 218

Genesee Herzberg — Ketamine Truths, MDMA Hopes, and the Work of...

AtaiBeckley Posts Positive Phase 2b Open-Label Extension Data for 5-MeO-DMT, Plots...

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin

atai Life Sciences to Participate in the Cowen 43rd Annual Health...

Psychedelic Health – Psychedelics Today: improving access to psychedelic therapy training

Mycoprenuer Podcast – Joe Moore & Kyle Buller: Psychedelics Today

Small Pharma to Present at Cowen’s 43rd Annual Health Care Conference

Convergence: Canceled

Optimi Health Enters Australian Medical MDMA And Psilocybin Market With Mind...

Algernon Pharmaceuticals Announces 4 for 1 Forward Share Split

Blossom – Making Psychedelic Education Accessible with David Drapkin from Psychedelics...

PT394 – We Are The Medicine

Fierce Healthcare – Psychedelics Today to offer yearlong certificate course on...

EDITOR PICKS

Genesee Herzberg — Ketamine Truths, MDMA Hopes, and the Work of...

AtaiBeckley Posts Positive Phase 2b Open-Label Extension Data for 5-MeO-DMT, Plots...

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY